Clearmind Medicine Inc. Increase Decrease In Fair Value Measurement Liabilities
Clearmind Medicine Inc. (CMND) reported Increase Decrease In Fair Value Measurement Liabilities of $377.47 thousand for the 3-month period ending 2025-01-31, per its 6-K filed 2025-03-13.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInFairValueMeasurementLiabilities · last filed 2025-03-13
- Clearmind Medicine Inc. increase decrease in fair value measurement liabilities for the quarter ending 2025-01-31 was $377.47K, a 70588.01% increase year-over-year.
- Clearmind Medicine Inc. increase decrease in fair value measurement liabilities for the quarter ending 2024-10-31 was $175.24K, a 17583.35% increase year-over-year.
- Clearmind Medicine Inc. increase decrease in fair value measurement liabilities for the quarter ending 2024-07-31 was $362.37K, a 2694.80% increase year-over-year.
- Clearmind Medicine Inc. increase decrease in fair value measurement liabilities for the quarter ending 2024-04-30 was $266.81K.
| Period end | Increase Decrease In Fair Value Measurement Liabilities 3 month | Increase Decrease In Fair Value Measurement Liabilities 6 month | Increase Decrease In Fair Value Measurement Liabilities 9 month | Increase Decrease In Fair Value Measurement Liabilities 12 month |
|---|---|---|---|---|
| 2025-01-31 | $377.47K 6-K · filed 2025-03-13 | $552.72K derived: sum of 2 quarters · filed 2025-03-13 | $915.09K derived: sum of 3 quarters · filed 2025-03-13 | $1.18M derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-10-31 | $175.24K derived: 20-F 12 month − 6-K 9 month · filed 2025-01-22 | $537.62K derived: sum of 2 quarters · filed 2025-01-22 | $804.43K derived: sum of 3 quarters · filed 2025-01-22 | $804.96K 20-F · filed 2025-01-22 |
| 2024-07-31 | $362.37K derived: 6-K 9 month − 6-K 6 month · filed 2024-09-16 | $629.19K derived: sum of 2 quarters · filed 2024-09-16 | $629.72K 6-K · filed 2024-09-16 | $630.71K derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-04-30 | $266.81K derived: 6-K 6 month − 6-K 3 month · filed 2024-06-13 | $267.35K 6-K · filed 2024-06-13 | $268.34K derived: sum of 3 quarters · filed 2025-03-13 | $281.30K derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-01-31 | $534.00 6-K · filed 2025-03-13 | $1.52K derived: sum of 2 quarters · filed 2025-03-13 | $14.49K derived: sum of 3 quarters · filed 2025-03-13 | |
| 2023-10-31 | $991.00 derived: 20-F 12 month − 6-K 9 month · filed 2025-01-22 | $13.96K derived: sum of 2 quarters · filed 2025-01-22 | $91.59K 20-F · filed 2025-01-22 | |
| 2023-07-31 | $12.97K derived: 6-K 9 month − 6-K 6 month · filed 2024-09-16 | $90.60K 6-K · filed 2024-09-16 | ||
| 2023-04-30 | $77.63K 6-K · filed 2024-06-13 |